APA način citiranja

Ning, Y., Gulley, J. L., Arlen, P. M., Woo, S., Steinberg, S. M., Wright, J. J., . . . Dahut, W. L. (2010). Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer. American Society of Clinical Oncology.

Čikaški stil citiranja

Ning, Yang-Min, et al. Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer. American Society of Clinical Oncology, 2010.

MLA način citiranja

Ning, Yang-Min, et al. Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer. American Society of Clinical Oncology, 2010.